| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.009 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |